Press Releases
TheraGenetics Appoints Dr. Heiner Dreismann as Chairman of the Board And Mr. Robert Forrester as Director
15th August 2007
Molecular Diagnostic Industry Expert and Financial Leader to Guide Company through Commercialization
TheraGenetics Closes £3M Series A Financing
10th July 2007
TheraGenetics announced the successful completion of a £3 million Series A venture financing round today.
TheraGenetics Names Richard P. Kivel Chief Executive Officer
25th April 2006
TheraGenetics today announced the appointment of Richard P. Kivel as Chief Executive Officer. Mr. Kivel has served as CEO or President of multiple early-stage life science companies including, BioBehavioral Diagnostics, Trinity PharmaSolutions and MolecularWare, Inc., an MIT spin-out acquired in June 2003.